Oncology

The patient demonstrated an excellent response to CAR T therapy, achieving complete remission with MRD-negative status, representing the deepest possi...

The future of multiple myeloma treatment is rapidly evolving with several groundbreaking immunotherapy approaches in development. Beyond current CAR T...

In the postoperative period following colorectal cancer surgery, effective communication of pathology results and risk assessment for recurrence are c...

Larry Jameson, J. & Longo, D. L. Precision medicine — personalized, problematic, and promising. Obstet. Gynecol. Surv. 70, 612 (2015). Gillies, R. J.,...

Pancreatic cancer is currently the 3rd leading cause of cancer related death in the United States [1]. Despite advances in our understanding of the bi...

Chronic myeloid leukemia (CML) was once known as a deadly disease, renowned for its difficulty to treat. Now, therapies exist such that, following ini...

The FDA has approved denosumab-nxxp as a 60 mg/mL injection (Bildyos) and denosumab-nxxp as a 120 mg/1.7 mL injection (Bilprevda) as biosimilars to de...

The triplet combination of encorafenib (Braftovi), cetuximab (Erbitux), and nivolumab (Opdivo) exhibited safety and early efficacy in patients with mi...

Daily use of interferon-alpha (IFN-α) as a nasal spray was found to reduce the incidence of COVID-19 for adult patients with cancer, according to resu...

After a long Labor Day Weekend, the FDA has made a number of decisions regarding various oncology treatments and has set meetings with a few developer...